Orthocell Overview

  • Founded
  • 2006
Founded
  • Status
  • Public
  • Stock Symbol
  • OCC
Stock Symbol
  • Share Price
  • $0.25
  • (As of Friday Closing)

Orthocell General Information

Description

Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialisation of cell therapies and related technologies. Its product includes CelGro is a naturally derived collagen medical device for tissue repair and Ortho-ATI is a first-in-class cell therapy for the treatment of chronic tendon injuries.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
ASX
Primary Office
  • Building 191 Murdoch University
  • South Street
  • Murdoch, Western Australia 6150
  • Australia
+61 (08) 0000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Orthocell Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.25 $0.25 $0.10 - $0.47 $45.9M 185M 519K -$0.02

Orthocell Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 26,275 26,275 40,673 21,004
Revenue 482 482 777 480
EBITDA (5,974) (5,974) (5,843) (6,069)
Net Income (4,123) (4,123) (4,184) (4,459)
Total Assets 15,921 15,921 9,523 3,842
Total Debt 344 344 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Orthocell Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Orthocell‘s full profile, request access.

Request a free trial

Orthocell Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialisation of cel
Pharmaceuticals
Murdoch, Australia
00.000
000000000 00.000

00000000

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sin
0000000000000
Canton, MA
000 As of 0000
00000
00000000000 00000

000000 0

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000000000000
Columbia, MD
000 As of 0000
000.00
0000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Orthocell Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Organogenesis Corporation Canton, MA 000 00000 00000000000 00000
000000 00000000000 Formerly VC-backed Columbia, MD 000 000.00 000000&0 000.00
00000000 Venture Capital-Backed Medford, MA 000.00 00000000000 000.00
To view Orthocell’s complete competitors history, request access »

Orthocell Executive Team (4)

Name Title Board Seat Contact Info
Nicole Telford Chief Financial Officer
Paul Anderson Managing Director
M. Zheng Ph.D Chief Scientific Officer
Leslie Wise Executive Director
To view Orthocell’s complete executive team members history, request access »

Orthocell Board Members (4)

Name Representing Role Since
Lars Lidgren Self Board Member 000 0000
Qi Xiao Zhou Self Board Member 000 0000
Stewart James Washer Self Chairman 000 0000
To view Orthocell’s complete board members history, request access »